Constance Care (WAR:CCR) Beta: 0.2331 (As of Jun. 25, 2026)


WAR:CCR Constance Care SA WAR:CCR
33 GF Score
Price zł6.00
GF Value zł0.15
Valuation Significantly Overvalued
View Full Analysis

What is Constance Care Beta?

Constance Care WAR:CCR 33 Beta is 0.2331 as of Jun. 25, 2026. GuruFocus rates WAR:CCR with a GF Score™ of 33/100 and a GF Value™ of zł0.15 (Significantly Overvalued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Constance Care's Beta is 0.2331.


Constance Care  (WAR:CCR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Constance Care Beta Related Terms


Constance Care Beta Historical Data

* Premium members only.

The historical data trend for Constance Care's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Constance Care Beta Chart

Constance Care Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.25 -0.99

Constance Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.49 1.14 -0.99 0.48

WAR:CCR vs HCA, UHS, CHE: Beta Comparison

For the Medical Care Facilities subindustry, Constance Care's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Constance Care Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Constance Care's Beta distribution charts can be found below:

* The bar in red indicates where Constance Care's Beta falls into.


WAR:CCR
33GF Score
Constance Care SA WAR:CCR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Constance Care Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.2331 mean?
Constance Care (WAR:CCR) has a Beta of 0.2331 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Constance Care and its competitors.
Is Constance Care's Beta too high?
Constance Care's current Beta is 0.2331. Overall, Constance Care has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's Beta compare to HCA and UHS?
Constance Care's Beta of 0.2331 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Constance Care and its competitors. Constance Care's current Beta is 0.2331. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł6.00 — trading 3900% above its estimated fair value. The current Beta is 0.2331. Constance Care's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current Beta is 0.2331 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Constance Care (WAR:CCR) Overvalued in 2026?

Based on GuruFocus' analysis, Constance Care stock appears to be overvalued. The current stock price of zł6.00 is trading 3900% above its estimated GF Value™ of zł0.15. GuruFocus considers Constance Care to be Significantly Overvalued.

Key valuation signals for WAR:CCR:

  • Beta: 0.2331
  • GF Value™: zł0.15 vs. price of zł6.00 (3900% above fair value)
  • GF Score™: 33/100

No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Constance Care Business Description

Address ul. Dzialkowa 125, Kierszek, POL, 05-500
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
33GF Score

Get the complete analysis for WAR:CCR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł6.00
Price
zł0.15
GF Value